替雷利珠单抗联合XELOX方案治疗晚期胃癌的效果及对肿瘤标志物、血管新生指标的影响

doi:10.3969/j.issn.1674-4985.2025.36.016

中国医学创新

2025, Vol. 22

Issue (36): 66-70 DOI: 10.3969/j.issn.1674-4985.2025.36.016

Clinical research

Current Issue | Archive | Adv Search

The Efficacy of Tislelizumab Combined with XELOX Regimen in the Treatment of Advanced Gastric Cancer and Its Influence on Tumor Markers and Angiogenesis Indicators

YU Mingyang, ZHANG Luyao, WANG Liyu, GUO Fen, WANG Guoqiang

First-author's address: Department of Oncology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou 215000, China　

Abstract
Figure/Table
References
Related Citation (15)